Put companies on watchlist
Lonza Group AG
ISIN: CH0013841017
WKN: 928619
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Lonza Group AG · ISIN: CH0013841017 · EQS - adhoc news (67 News)
Country: Switzerland · Primary market: Switzerland · EQS NID: 1730915
21 September 2023 07:00AM

Lonza Confirms Details of Capital Markets Day and Reconfirms Outlook 2023


Lonza Group AG / Key word(s): Forecast
Lonza Confirms Details of Capital Markets Day and Reconfirms Outlook 2023

21-Sep-2023 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Ad hoc announcement pursuant to Art. 53 LR

  • Capital Markets Day 2023 will be hosted by members of the Lonza Executive Committee
  • The presentation will provide an overview of Lonza’s offerings, capabilities, markets and sources of competitive advantage
  • Lonza reconfirms Outlook 2023 at mid-to-high single-digit CER sales growth and 28 to 29% CORE EBITDA margin

Basel, Switzerland, 21 September 2023 – Lonza today announced its plans for the company’s Capital Markets Day, which is scheduled to take place on 17th October 2023.

There will be updates provided by each of Lonza’s four Divisional Presidents, including the following topics: the markets in which each division operates, main offerings and capabilities, sources of competitive advantage, and current growth projects. The Chief Financial Officer will also provide an update on Lonza’s financial profile and prospects. Following the presentation, there will be a Q&A session, and a tour of the Lonza Visp manufacturing facilities, for those attending in person. 

Alongside the details of the Capital Markets Day, Lonza is also reconfirming its Outlook 2023. During the company’s Half-Year Results presentation in July 2023, the Outlook was set at mid-to-high single-digit CER sales growth and 28 to 29% CORE EBITDA margin.

Albert M. Baehny, Chairman and CEO ad interim, Lonza, commented: “As we prepare for the Capital Markets Day, we are pleased with Lonza’s strong business fundamentals and confident in our capability to drive long-term value creation. Our meeting in October is an opportunity for our participants to share their questions and views, and I am greatly looking forward to an open discussion on the important topics that are relevant to our business.”

While all available spaces are now reserved for the Capital Markets Day in-person event, investors are still welcome to join the waiting list or register for online participation.

About Lonza
Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Our business is structured to meet our customers' complex needs across four divisions: Biologics, Small Molecules, Cell & Gene and Capsules & Health Ingredients.Our unparalleled breadth of offerings across divisions enables our customers to commercialize their discoveries and innovations in the healthcare industry.

Founded in 1897 in the Swiss Alps, today, Lonza operates across five continents. With more than 17,500 full-time employees, we comprise high-performing teams and individual talent who make a meaningful difference to our own business, as well as to the communities in which we operate. The company generated sales of CHF 3.1 billion with a CORE EBITDA of CHF 922 million in Half-Year 2023. Find out more at www.lonza.com.

Follow @Lonza on LinkedIn
Follow @LonzaGroup on Twitter

Lonza Contact Details

Victoria Morgan
Head of External Communications
Lonza Group Ltd
Tel +41 61 316 2283
victoria.morgan@lonza.com

Lyle Wheeler
Investor Relations
Lonza Group Ltd
Tel +41 79 154 9522
lyle.wheeler@lonza.com



End of Inside Information
Language: English
Company: Lonza Group AG
Münchensteinerstrasse 38
4052 Basel
Switzerland
Phone: +4161 316 81 11
Internet: www.lonza.com
ISIN: CH0013841017
Valor: 1384101
Listed: SIX Swiss Exchange
EQS News ID: 1730915

 
End of Announcement EQS News Service

1730915  21-Sep-2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1730915&application_name=news&site_id=boersengefluester
Visual performance / price development - Lonza Group AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.